 | INHIBITION OF MATRIX METALLOPROTEINASES THERAPEUTIC APPLICATIONS
Copyright © 1999 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 878:361-371 (1999)
© 1999 New York Academy of Sciences
Specialized Surface Protrusions of Invasive Cells, Invadopodia and Lamellipodia, Have Differential MT1-MMP, MMP-2, and TIMP-2 Localization
WEN-TIEN CHENa AND
JAW-YUAN WANG
Department of Medicine/Medical Oncology, State University of New York at Stony Brook, Stony Brook, New York 11794-8160, USA
aAddress for correspondence: Wen-Tien Chen, Ph.D., Department of Medicine/Medical Oncology, HSC T-16, Rm. 020, SUNY Stony Brook, New York 11794-8160. Phone; 516/444-6948; 444-7594 (lab); fax, 516/444-2493; e-mail, wchen{at}mail.som.sunysb.edu
Surface protrusions, invadopodia, and analogous lamellipodia at the leading edge of an invasive cell, which make contact with the underlying extracellular matrix (ECM), are the main motor for cellular locomotion and invasion. Previous studies have demonstrated that invadopodia, but not lamellipodia, are sites of ECM degradation on the cell surface. Such degradative activity is in part due to the localization of latent matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) to invadopodia, where MMP activation occurs. Although lamellipodia exhibit similar structure and mobility to invadopodia, lamellipodia, by virtue of their location at the cellular periphery, are readily accessible to the soluble tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) and blood-borne inhibitors. We show here that TIMP-2 co-localizes with MT1-MMP and MMP-2 at lamellipodia but not with that of invadopodia. Thus, the MMP-TIMP localization at lamellipodia may be a key mechanism for the regulation of MMP activation on the cell surface, which in turn governs expression of the cell-invasive phenotype.
This article has been cited by other articles:
|
|
|
|
 
M. Sakurai-Yageta, C. Recchi, G. Le Dez, J.-B. Sibarita, L. Daviet, J. Camonis, C. D'Souza-Schorey, and P. Chavrier
The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA
J. Cell Biol.,
June 16, 2008;
181(6):
985 - 998.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Clark, A. S. Whigham, W. G. Yarbrough, and A. M. Weaver
Cortactin Is an Essential Regulator of Matrix Metalloproteinase Secretion and Extracellular Matrix Degradation in Invadopodia
Cancer Res.,
May 1, 2007;
67(9):
4227 - 4235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stefanidakis and E. Koivunen
Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression
Blood,
September 1, 2006;
108(5):
1441 - 1450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Eves, B. A. Webb, S. Zhou, and A. S. Mak
Caldesmon is an integral component of podosomes in smooth muscle cells
J. Cell Sci.,
May 1, 2006;
119(9):
1691 - 1702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Brabek, S. S. Constancio, P. F. Siesser, N.-Y. Shin, A. Pozzi, and S. K. Hanks
Crk-Associated Substrate Tyrosine Phosphorylation Sites Are Critical for Invasion and Metastasis of Src-Transformed Cells
Mol. Cancer Res.,
June 1, 2005;
3(6):
307 - 315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yamaguchi, M. Lorenz, S. Kempiak, C. Sarmiento, S. Coniglio, M. Symons, J. Segall, R. Eddy, H. Miki, T. Takenawa, et al.
Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin
J. Cell Biol.,
January 31, 2005;
168(3):
441 - 452.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Imaging Proteolysis in Living Organotypic Models of Cancer: BONNIE F. SLOANE, MANSOUREH SAMENI, STEFANIE ROSHY, IZABELA PODGORSKI, JULIE DOSESCU, BRUCE LINEBAUGH, MICHAEL CHER, AND KAMIAR MOIN, Departments of Pharmacology, Urology and Pathology, Wayne State University and Proteases and Cancer Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201
Toxicol Pathol,
January 1, 2004;
32(1):
152 - 153.
[PDF]
|
|
|
|
|
|
|
L. Rosano, F. Spinella, V. Di Castro, M. R. Nicotra, A. Albini, P. G. Natali, and A. Bagnato
Endothelin Receptor Blockade Inhibits Molecular Effectors of Kaposi's Sarcoma Cell Invasion and Tumor Growth in Vivo
Am. J. Pathol.,
August 1, 2003;
163(2):
753 - 762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Ritch, S. L. Carroll, and H. Sontheimer
Neuregulin-1 Enhances Motility and Migration of Human Astrocytic Glioma Cells
J. Biol. Chem.,
May 30, 2003;
278(23):
20971 - 20978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Baldassarre, A. Pompeo, G. Beznoussenko, C. Castaldi, S. Cortellino, M. A. McNiven, A. Luini, and R. Buccione
Dynamin Participates in Focal Extracellular Matrix Degradation by Invasive Cells
Mol. Biol. Cell,
March 1, 2003;
14(3):
1074 - 1084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ghersi, H. Dong, L. A. Goldstein, Y. Yeh, L. Hakkinen, H. S. Larjava, and W.-T. Chen
Regulation of Fibroblast Migration on Collagenous Matrix by a Cell Surface Peptidase Complex
J. Biol. Chem.,
August 2, 2002;
277(32):
29231 - 29241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Zhang, C. Li, and P. C. Baciu
Expression of Integrins and MMPs during Alkaline-Burn-Induced Corneal Angiogenesis
Invest. Ophthalmol. Vis. Sci.,
April 1, 2002;
43(4):
955 - 962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gilles, M. Polette, C. Coraux, J.-M. Tournier, G. Meneguzzi, C. Munaut, L. Volders, P. Rousselle, P. Birembaut, and J.-M. Foidart
Contribution of MT1-MMP and of human laminin-5 {gamma}2 chain degradation to mammary epithelial cell migration
J. Cell Sci.,
March 10, 2002;
114(16):
2967 - 2976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. V. Rozanov, B. Ghebrehiwet, T. I. Postnova, A. Eichinger, E. I. Deryugina, and A. Y. Strongin
The Hemopexin-like C-terminal Domain of Membrane Type 1 Matrix Metalloproteinase Regulates Proteolysis of a Multifunctional Protein, gC1qR
J. Biol. Chem.,
March 8, 2002;
277(11):
9318 - 9325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Adams
Regulation of protrusive and contractile cell-matrix contacts
J. Cell Sci.,
January 15, 2002;
115(2):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. I. Deryugina, L. Soroceanu, and A. Y. Strongin
Up-Regulation of Vascular Endothelial Growth Factor by Membrane-type 1 Matrix Metalloproteinase Stimulates Human Glioma Xenograft Growth and Angiogenesis
Cancer Res.,
January 1, 2002;
62(2):
580 - 588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Weed, A. V. Karginov, D. A. Schafer, A. M. Weaver, A. W. Kinley, J. A. Cooper, and J. T. Parsons
Cortactin Localization to Sites of Actin Assembly in Lamellipodia Requires Interactions with F-Actin and the Arp2/3 Complex
J. Cell Biol.,
September 25, 2000;
151(1):
29 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. V. Rozanov, E. I. Deryugina, B. I. Ratnikov, E. Z. Monosov, G. N. Marchenko, J. P. Quigley, and A. Y. Strongin
Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP). THE ROLE OF THE CYTOPLASMIC TAIL CYS574, THE ACTIVE SITE GLU240, AND FURIN CLEAVAGE MOTIFS IN OLIGOMERIZATION, PROCESSING, AND SELF-PROTEOLYSIS OF MT1-MMP EXPRESSED IN BREAST CARCINOMA CELLS
J. Biol. Chem.,
July 6, 2001;
276(28):
25705 - 25714.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Lehti, H. Valtanen, S. Wickstrom, J. Lohi, and J. Keski-Oja
Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain
J. Biol. Chem.,
May 12, 2000;
275(20):
15006 - 15013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Silletti, T. Kessler, J. Goldberg, D. L. Boger, and D. A. Cheresh
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
PNAS,
January 2, 2001;
98(1):
119 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Uekita, Y. Itoh, I. Yana, H. Ohno, and M. Seiki
Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity
J. Cell Biol.,
December 24, 2001;
155(7):
1345 - 1356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
